AG真人官方

On 07/28/2025 Scotts Miracle-Gro (SMG) Chairman & CEO James Hagedorn filed a Form 4 reporting one derivative transaction.

• Security: Phantom stock units representing the cash value of one SMG common share each.
• Quantity acquired: 1,301.236 units (transaction code 鈥淎鈥�).
• Reference price: $69.42 per unit.
• Post-transaction balance: 220,543.082 phantom stock units held directly.
• Payout terms: Units settle in cash after employment ends; the holder may switch to other investments at any time.

No non-derivative common shares were bought or sold, so the public float is unchanged. The filing records deferred-compensation accrual rather than open-market trading and therefore has limited direct market impact.

Scotts Miracle-Gro (SMG) 鈥� Form 4 insider filing

EVP, CFO & CAO Mark J. Scheiwer reported acquiring 8.193 phantom stock units on 28-Jul-2025 at a reference value of $69.42. Each unit is economically equivalent to one common share but is settled in cash after the executive leaves the company. Following the award, Scheiwer beneficially owns 1,055.1 phantom units; no changes were reported in his direct or indirect ownership of SMG common shares.

The transaction was coded 鈥淎鈥� (award) and appears to be a routine addition under the company鈥檚 deferred-compensation plan rather than an open-market purchase. Given the small size of the award relative to SMG鈥檚 ~55 million shares outstanding, the filing is unlikely to have a material impact on float, liquidity or near-term valuation.

On 06/25/2025, President & COO (and 10% owner) Nathan Eric Baxter filed a Form 4 reporting the acquisition of 93.7383 common shares of The Scotts Miracle-Gro Company (SMG) at $53.34 per share (transaction code J). After the purchase, his direct holdings total 50,602.6841 shares, while 36,993 shares remain held indirectly through Hagedorn Partnership, L.P. No derivative security activity was disclosed, and the filing does not amend any prior report. The transaction increases Baxter鈥檚 direct stake by roughly 0.19%, an immaterial amount relative to his overall ownership and SMG鈥檚 share count, indicating a routine adjustment rather than a strategic accumulation. Nevertheless, the buy modestly reinforces executive-shareholder alignment because it adds to an already significant insider position.

On 06/25/2025, President & COO (and 10% owner) Nathan Eric Baxter filed a Form 4 reporting the acquisition of 93.7383 common shares of The Scotts Miracle-Gro Company (SMG) at $53.34 per share (transaction code J). After the purchase, his direct holdings total 50,602.6841 shares, while 36,993 shares remain held indirectly through Hagedorn Partnership, L.P. No derivative security activity was disclosed, and the filing does not amend any prior report. The transaction increases Baxter鈥檚 direct stake by roughly 0.19%, an immaterial amount relative to his overall ownership and SMG鈥檚 share count, indicating a routine adjustment rather than a strategic accumulation. Nevertheless, the buy modestly reinforces executive-shareholder alignment because it adds to an already significant insider position.

On 06/25/2025, President & COO (and 10% owner) Nathan Eric Baxter filed a Form 4 reporting the acquisition of 93.7383 common shares of The Scotts Miracle-Gro Company (SMG) at $53.34 per share (transaction code J). After the purchase, his direct holdings total 50,602.6841 shares, while 36,993 shares remain held indirectly through Hagedorn Partnership, L.P. No derivative security activity was disclosed, and the filing does not amend any prior report. The transaction increases Baxter鈥檚 direct stake by roughly 0.19%, an immaterial amount relative to his overall ownership and SMG鈥檚 share count, indicating a routine adjustment rather than a strategic accumulation. Nevertheless, the buy modestly reinforces executive-shareholder alignment because it adds to an already significant insider position.

On 06/25/2025, President & COO (and 10% owner) Nathan Eric Baxter filed a Form 4 reporting the acquisition of 93.7383 common shares of The Scotts Miracle-Gro Company (SMG) at $53.34 per share (transaction code J). After the purchase, his direct holdings total 50,602.6841 shares, while 36,993 shares remain held indirectly through Hagedorn Partnership, L.P. No derivative security activity was disclosed, and the filing does not amend any prior report. The transaction increases Baxter鈥檚 direct stake by roughly 0.19%, an immaterial amount relative to his overall ownership and SMG鈥檚 share count, indicating a routine adjustment rather than a strategic accumulation. Nevertheless, the buy modestly reinforces executive-shareholder alignment because it adds to an already significant insider position.

The latest Form 4 filing for The Scotts Miracle-Gro Company (SMG) shows a routine equity-compensation event rather than an open-market purchase. On 01 July 2025, director Stephen L. Johnson received 215 Deferred Stock Units (DSUs) in lieu of a cash retainer worth $14,375, corresponding to an implied price of approximately $67.10 per share. The transaction is coded 鈥淎,鈥� confirming it is an acquisition, and it raises the director鈥檚 direct holdings to 27,161 common shares.

No derivative securities, dispositions, or 10b5-1 plan designations are reported, and no other insiders are involved. While the dollar amount is immaterial to SMG鈥檚 financial position, the award marginally increases insider ownership and aligns board incentives with shareholder interests. There are no red flags or governance concerns indicated in this short filing.

JPMorgan Chase Financial Company LLC is offering $89,000 in unsecured Structured Review Notes linked to the MerQube US Tech+ Vol Advantage Index (ticker: MQUSTVA). The five-year notes, fully and unconditionally guaranteed by JPMorgan Chase & Co., price at $1,000 per note (minimum $1,000 denominations) and settle on or about 3 July 2025.

Investment mechanics

• Automatic call feature: If on any of the five annual Review Dates (first on 7 July 2026) the Index closes at or above the Call Value (100 % of the Initial Value), the notes are redeemed early for $1,000 plus a predetermined Call Premium that escalates from 21.75 % to 108.75 % of principal.
• Principal protection: Absent an automatic call, investors receive par only if the Index decline does not exceed the 30 % Buffer. Below that threshold, principal is reduced 1-for-1, up to a maximum 70 % loss.
• Index drag: The Index incurs a 6.0 % p.a. daily deduction plus a daily notional financing cost tied to SOFR+0.50 %. These charges may materially offset gains and amplify losses.
• Leverage & volatility targeting: Weekly rebalancing sets exposure to the QQQ Fund at 35 % 梅 implied volatility, capped at 500 %. Leverage magnifies both positive and negative moves.
• Pricing & fees: Investors pay a $5 selling commission (0.50 %). Estimated value on pricing date is $946.80, 5.32 % below issue price, reflecting structuring and hedging costs.

Risk highlights

• Up to 70 % capital loss at maturity if the Buffer is breached and no call occurs.
• Performance lag versus a similar index without deductions; upside limited exclusively to the fixed Call Premiums.
• No interest, no dividends, no listing; liquidity dependent on JPMS bid.
• Credit exposure to both JPMorgan Financial (finance subsidiary with limited assets) and JPMorgan Chase & Co.
• Pervasive conflicts of interest: JPM affiliates helped design the Index, own 10 % of the Index Sponsor, and act as calculation agent, hedger and market-maker.

Key dates & levels

• Pricing Date: 30 June 2025 (Initial Value 11,152.41)
• Final Review Date: 1 July 2030; Maturity: 5 July 2030
• CUSIP: 48136EQN8

Investors must weigh the rich headline Call Premiums and 30 % downside buffer against significant structural drags, leveraged volatility, illiquidity and issuer credit risk.

Toronto-Dominion Bank is offering $711,000 aggregate principal amount of Callable Contingent Interest Barrier Notes maturing on 30 June 2028. The Notes are linked to the least-performing of three major U.S. equity benchmarks: Nasdaq-100 (NDX), Russell 2000 (RTY) and S&P 500 (SPX). They are senior, unsecured debt obligations of TD and are subject to the bank鈥檚 credit risk.

The Notes pay a contingent coupon of ~9.70% p.a. (calculated monthly) only when, on the corresponding observation date, the closing level of each index is at least 70 % of its initial level (the Contingent Interest Barrier). TD may call the Notes in whole, at its discretion, on any monthly payment date starting with the sixth coupon date; if called, investors receive the $1,000 principal plus any earned coupon, and no further payments.

If the Notes are not called, repayment at maturity depends on index performance. Full principal is returned only when the final level of each index is at least 60 % of its initial level (Barrier Value). If any index closes below its Barrier Value, investors incur a loss equal to the percentage decline of the worst-performing index and could lose up to 100 % of their investment.

• Issue price: $1,000 per Note; underwriting discount: $7.00; net proceeds to TD: $993.00.
• Estimated value on the pricing date: $986.10 per Note, below the public offering price.
• Denominations: $1,000 and integral multiples thereof; CUSIP 89115HH42.
• No exchange listing; secondary trading may be limited and subject to differing prices.

The product offers high conditional income and 40 % downside barrier, balanced against equity market, call, credit and liquidity risks.